Polylaminin
From Wikipedia, the free encyclopedia
Polylaminin or polyLM, is a stabilized form of laminin, a family of natural proteins, which is being studied for use in treating spinal cord injuries in animals and humans.[1][2][3] In early human trials, a patient with a fractured neck vertebra after a car accident had a full recovery after a year, and a chronic quadriplegic patient regained arm movement.[4][5][6] The Brazilian Academy of Neurology, Brazilian Academy of Sciences, and the Brazilian Society for the Progress of Science advise caution before clinical tests are completed.[7]
